Estrogen hormone binding to either of its receptors, estrogen receptor α and β (ERα and β), through extranuclear signaling can drive actin cytoskeleton modification, cancer cell migration, invasion, and metastasis via phosphorylation of moesin in ER-positive breast cancer cells [90]. This evidence concerns the gene ESR1 and breast carcinoma.